Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Oncolytics Biotech Inc. reported a net loss of $28.4 million for the nine months ended September 30, 2026, compared to $19.9 million in the prior year period, driven by increased R&D and G&A expenses. The company's cash position decreased to $2.4 million, leading management to issue a going concern warning as existing resources are insufficient to fund operations for the next twelve months.
Gaxos.ai reported Q3 2026 financial results featuring record consolidated revenue of $2.81 million, a 464.9% increase year-over-year. The company highlighted improved operational efficiency, with revenue per dollar of advertising expense increasing 38% sequentially to $1.08. As of September 30, 2026, the company maintained a cash position of approximately $13.30 million.
Term
Q3 2026
“Our third quarter results show continued revenue growth alongside lower advertising and marketing expense. We achieved record consolidated revenue while improving revenue per dollar of advertising and marketing expense by approximately 38% from the second quarter. We remain focused on improving customer acquisition efficiency and scaling products and channels with favorable contribution economics.”
Vadim Mats, CEO of Gaxos
“We are continuously fine-tuning our approach to customer acquisition. Our revenue generated per advertising dollar showed significant improvement as we work on strategy As always, we strive to continue building on our progress.”
FiEE, Inc. reported its third quarter 2026 financial results, highlighted by a significant revenue surge of 382.1% to $9.6 million for the first nine months of the year. The company achieved a profit turnaround with net income of $3.6 million for the nine-month period, driven by a strategic shift from legacy hardware to AI-integrated SaaS and digital art advisory services.
Term
Q3 2026
“We delivered solid financial results during the period and made meaningful progress in building a more diversified, scalable digital services platform.”
Rafael Li, Chief Executive Officer and President of FiEE
CO2 Energy Transition Corp. reported net income of $680,745 for the nine months ended September 30, 2026, primarily driven by $1.58 million in interest earned on trust account investments. During the period, the company experienced significant redemptions, with common stock subject to possible redemption decreasing from 6,900,000 shares to 1,030,715 shares.
Churchill Capital Corp XII is a shell company that completed its IPO on April 29, 2026, raising $414 million held in a Trust Account for a future business combination. As of September 30, 2026, the company has 41,750,000 Class A and 13,800,000 Class B ordinary shares outstanding and is classified as an emerging growth company.
Churchill Capital Corp XIII is a shell company that completed its initial public offering on August 3, 2026, raising $414,000,000 held in a U.S.-based trust account. As of September 30, 2026, the company is in its search phase for an initial business combination and has until at least August 3, 2028, to consummate a transaction.
Forge Nano reported total net sales of $6.07 million for the nine months ended September 30, 2026, a 14% increase year-over-year, though it faced a significant gross loss of $5.04 million. The company's net loss widened to $44.5 million for the period, driven by increased operating expenses and an $11.2 million nonoperating expense related to debt and warrant fair value changes.
Enveric Biosciences reported a net loss of $7.21 million for the nine months ended September 30, 2026, compared to $6.58 million in the prior year period, driven by increased research and development costs. The company strengthened its cash position to $5.61 million through various financing activities, including private placements and warrant exercises, resulting in a total shareholders' equity of $5.73 million.
Empire Petroleum reported a net loss of $12.0 million for the nine months ended September 30, 2026, compared to a $13.1 million loss in the prior year period. While total product revenues increased to $29.2 million, the company's bottom line was impacted by a $5.0 million loss on derivatives and significant operating expenses.
Auddia Inc. reported a net loss of $7.37 million for the nine months ended September 30, 2026, compared to a $5.70 million loss in the prior year period. While the company began generating modest revenue of $22,268, operating expenses increased significantly due to higher sales, marketing, and transaction costs related to a proposed merger with Thramann Holdings.
WhiteHawk Minerals Corp. reported a net loss of $33.4 million for the nine months ended September 30, 2026, primarily driven by a $21.7 million loss on debt extinguishment and increased management fees. Despite the year-to-date loss, the company achieved a net income of $6.9 million in the third quarter of 2026, supported by $17.0 million in royalty revenue and a $3.2 million gain on commodity derivatives.
URSB Bancorp, Inc. reported net income of $653 thousand for the nine months ended September 30, 2026, compared to $327 thousand in the prior year period. The company completed its initial public offering during the first quarter of 2026, significantly increasing total shareholders' equity to $39.3 million.
Aptera Motors Corp. reported a net loss of $35.0 million for the nine months ended September 30, 2026, compared to a $28.4 million loss in the prior year period, driven by increased research and development costs. The company remains in the development stage with zero revenue and a total accumulated deficit of $353.7 million as of the reporting date.
DataMEDS AI reported Q3 2026 revenue of $2.7 million, representing 50% sequential growth driven by its Corexa Pharmacy drug dispensing business. The company achieved a net profit of $2.72 per share and regained full compliance with Nasdaq listing standards during the period. Key strategic developments included the launch of the Health Lives Here mobile app and the acquisition of the Helomics cancer diagnostics laboratory.
Term
Q3 2026
“Corexa Pharmacy drove a 50% sequential increase in revenue this quarter with continued growth expected for the fourth quarter based upon the steps we have taken to add additional revenue streams of medical foods and diagnostic lab tests related to patients to whom we dispense prescriptions.”
Velos Acquisition I Corp. reported a net income of $2.90 million for the nine months ended September 30, 2026, primarily driven by $7.31 million in interest earned on Trust Account investments. During the period, the company experienced significant redemptions of Class A ordinary shares totaling $135.52 million and converted all Class B ordinary shares into Class A ordinary shares.
Vistagen reported a net loss primarily driven by research and development expenses for its CNS pipeline, including Phase 3 trials for fasedienol. The company maintains a cash runway to support operations through upcoming clinical milestones, though it currently generates no product revenue.
Lifeloc Technologies reported a net loss of $84,931 for the third quarter of 2026, an improvement from the $263,439 loss in the prior year period, driven by a 12% increase in total revenues. For the nine months ended September 30, 2026, the company reduced its operating loss to $281,649 compared to $893,139 in 2025, while securing a $500,000 related-party term loan to bolster cash reserves.
Hennessy Capital Investment Corp. VIII reported net income of $4.09 million for the nine months ended September 30, 2026, primarily driven by $5.41 million in interest earned on cash held in the Trust Account. As a blank check company, it has not yet commenced operations or selected a business combination target, and it maintains a shareholders' deficit of $4.96 million due to the accretion of Class A ordinary shares to redemption value.
AEVEX Corp. reported Q3 2026 revenue of $189.7 million, a 56.5% increase year-over-year, driven by growth in its Airborne Systems segment and the acquisition of BlackSea Technologies. The company raised its full-year 2026 revenue guidance to a range of $820-$840 million and Adjusted EBITDA guidance to $128-$132 million. Despite revenue growth, the company reported a net loss of $16.8 million primarily due to a significant increase in income tax provisions.
Term
Q3 2026
“AEVEX delivered strong third-quarter results with total revenue and Adjusted EBITDA growth, and related margin expansion. Beyond the success in our legacy business, we announced and closed on our first acquisition as a public company, with the purchase of BlackSea Technologies. This combination expands our capabilities across air, surface and subsea domains, strengthens our production infrastructure and is creating new opportunities to deliver collaborative, mission-focused solutions to a broader set of customers.”
Roger Wells, Chief Executive Officer of AEVEX
“The strength of our third quarter performance, end market demand and the addition of BlackSea gives us the confidence to raise our full-year outlook. We look forward to continuing to advance the strategic priorities we outlined at the IPO earlier this year, as we are scaling production, broadening our mission and customer reach, investing ahead of the threat and building a differentiated multi-domain autonomous systems company.”
American Drive Acquisition Company reported a net income of $4,267,562 for the nine months ended September 30, 2026, primarily driven by $6,221,191 in interest earned on marketable securities held in the Trust Account. The company remains a shell company with $236,450,412 in its Trust Account and 23,000,000 Class A ordinary shares subject to possible redemption.
Ashford Hospitality Trust reported a net income of $14.2 million for the quarter ended September 30, 2026, a significant improvement from a $62.7 million loss in the prior year period, primarily driven by a $59.3 million gain on the disposition of assets. Total hotel revenue decreased to $214.3 million from $265.7 million year-over-year, reflecting a smaller portfolio as the company continues to divest properties and address debt.
Laird Superfood reported a significant increase in net sales to $41.95 million for the third quarter of 2026, compared to $12.90 million in the prior year period. The company achieved a net income of $1.73 million for the quarter, a substantial improvement from a net loss of $975,066 in Q3 2025, driven by higher gross profits and a change in the fair value of contingent consideration.
MDB Capital Holdings reported a net loss of $32.5 million for the nine months ended September 30, 2026, compared to a $19.5 million loss in the prior year, driven largely by a $13.2 million loss from an equity method investee and significant unrealized losses on investment securities. Total assets decreased from $63.7 million at year-end 2025 to $37.5 million, primarily due to the impairment and losses associated with their equity method investment.
Inhibrx Biosciences reported a net loss of $108.8 million for the nine months ended September 30, 2026, compared to $107.2 million in the prior year. The company significantly increased its cash position to $199.5 million following $175.0 million in debt proceeds, while its accumulated deficit grew to $355.0 million.
For the nine months ended September 30, 2026, Sculptor Diversified Real Estate Income Trust reported total revenues of $46.7 million and net income of $20.1 million, a significant improvement from the $1.6 million net loss in the prior year period. The company's total assets grew to $1.06 billion, driven by increased investments in real estate debt and unconsolidated entities.
Investcorp Credit Management BDC reported financial results for its fiscal quarter ended September 30, 2026, showing a net investment loss of $1.8 million ($0.13 per share). Net asset value (NAV) decreased to $3.02 per share from $3.44 in the prior quarter, driven by $3.0 million in net unrealized losses. Management waived all management and incentive fees for the period to support the company's financial position.
Term
Q1 2027
“Our focus this quarter was to maintain asset quality as we evaluated strategic alternatives to enhance shareholder value”
Suhail A. Shaikh, chief executive officer of ICMB
“Liquidity remained a high priority for us during the quarter.”
Kennedy Lewis Capital Company reported total investment income of $94.3 million and net investment income of $52.1 million for the nine months ended September 30, 2026. Total assets grew to $1.38 billion, driven by an increase in the fair value of the investment portfolio, while net asset value per share for Class I shares decreased slightly from $20.04 to $19.74 during the period.
Finward Bancorp reported net income of $5.7 million for the first nine months of 2026, a slight decrease from $6.1 million in the prior year period. Total assets decreased slightly to $2.01 billion as of September 30, 2026, while stockholders' equity was significantly impacted by a $21.9 million unrealized loss on securities available-for-sale.
For the nine months ended September 30, 2026, Mobility reported net sales of $2,480 million, a slight increase from $2,422 million in the prior year, while net income rose to $140 million from $123 million. The company is currently preparing for a Reverse Morris Trust transaction to combine with Dana Incorporated, which is expected to close in the first four months of 2027.
Bain Capital GSS Investment Corp. reported net income of $12.17 million for the nine months ended September 30, 2026, primarily driven by $13.02 million in interest earned on trust account deposits. As a shell company, it continues to seek a business combination while maintaining a shareholders' deficit of $16.05 million due to the redemption value of Class A ordinary shares.